News

iron bioresorbable scaffold Biotyx Medical

Ultrathin iron bioresorbable scaffold shows promise in first randomized trial

An investigational device could help interventional cardiologists avoid the limitations of drug-eluting stents, according to a new analysis published in JACC.

Nathaniel Lebowitz, MD, in charge of preventive cardiology at Hackensack University Medical Center, and assistant professor of internal medicine at Hackensack Meridian School of Medicine, gives an overview of where things are at with lipoprotein (a) awareness, testing and drug development. He and is working on the American Heart Associations (AHA) Lp(a) Discovery Project to expand awareness to both physicians and patients. #AHA #LPA

Cardiologist discusses Lp(a), the CVD risk factor responsible for many surprise heart attacks

Cardiologist Nathaniel Lebowitz, MD, reviews the latest updates in lipoprotein(a) awareness, testing and drug development.

REVENUE MONEY INCREASE DOLLAR GRAPH FINANCE

Edwards celebrates double-digit TAVR sales growth in Q4

It was another strong quarter for Edwards Lifesciences as the company's TAVR platform continues to gain momentum. The FDA's approval of multiple Edwards valves for the treatment of asymptomatic severe AS represents a potential game-changer for the entire industry.

Jane E Wilcox, MD, and Neil G. Bluhm. Image courtesy of Northwestern.

Billionaire donates $50M to advance cardiovascular care at Northwestern

Neil G. Bluhm, a billionaire philanthropist with deep ties to Chicago, has donated an additional $50 million to a high-volume facility that already bears his name.

New heart catheter for cell therapy delivery 1 step closer to FDA approval

The BioCardia delivery catheter was designed to be used by interventional cardiologists, electrophysiologists or cardiac surgeons. It includes a tiny needle that directly engages with the patient’s cardiac tissue.

Blue ribbon panel of experts shares advice on improving fluoroscopy safety: 5 takeaways

The American College of Radiology recently brought together thought leaders from 32 different organizations to come up with ways to standardize care when using this popular imaging system.

Hologic clears key hurdles in proposed $18B sale to private equity

Both company shareholders and Chinese regulators have approved the sale, with TPG and Blackstone anticipating they'll take the reins by April.

Johns Hopkins radiology chair steps down, Philips renews CEO contract, plus more leadership moves

In other news, NYU Langone Health recently named a new radiation oncology chair, a Lumexa Imaging rad is joining the RSNA board, and SNMMI has appointed an editor for its flagship journal.

Humana and Google partner on healthcare AI ‘Agent Assist’ for improved member support

The insurer said Google’s Gemini was part of the new AI’s core development. The system will support customer service interactions by automatically summarizing calls and pulling up relevant information, without the need for manual input. The Google Cloud will be providing the necessary data security to ensure patient privacy, the companies added.

UChicago integrates iMRI technology into surgery workflows

University of Chicago 1 of select few in US using new intraoperative MRI tech to bolster surgical workflows

Providers who have used iMRI so far have shared high praise for the added capabilities it affords them during operations.

warning safety alert recall healthcare issue

Safety update: New recommendations for managing patients with high-risk defibrillation leads

HRS has shared an updated guidance on managing Boston Scientific defibrillation leads at risk of experiencing a significant malfunction. The issue, first reported in July 2025, is believed to impact approximately 350,000 leads still being used today.

Andres Cordova, MD, cardiology fellow, University of Vermont Medical Center, explains a study of registry and outcomes data on the use of Impella hemodynamic support in elderly STEMI patients with cardiogenic shock.

Impella use fails to improve mortality in elderly patients

The Impella CP heart pump is being used more and more to treat cardiogenic shock, and the benefits are clear. For many older patients, however, the technology seem to fall short.

Around the web

Cardiovascular Business

Ultrathin iron bioresorbable scaffold shows promise in first randomized trial

An investigational device could help interventional cardiologists avoid the limitations of drug-eluting stents, according to a new analysis published in JACC.